MVM Life Science Partners is a London-based venture capital firm with an additional office located in Boston. The firm finances and builds early stage and expansion/late stage life science companies that develop new technology with a clear focus on products for major markets. MVM has specifically invested in bio-pharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare IT, healthcare services, medical devices, OTC medicines, research tools and vaccines. The firm invests in Europe, North America and Israel, as well as globally.
Venture Capital
6 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.